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Abstract: Regioselective Grignard reagent additions to 3-methoxy-
maleimides and subsequent diastereoselective reductive dehydrox-
ylation of the resulting N,O-acetals were studied. On the basis of
these studies, a flexible and highly regio- and diastereoselective ap-
proach to methyl 5-alkyltetramate derivatives was disclosed. The
method is the first direct and flexible asymmetric cationic synthon-
based approach, and allows for the synthesis of various methyl (5S)-
5-alkyltetramate derivatives that are otherwise inaccessible by the
commonly used methods based on a-amino acids.
Key words: tetramates, Grignard reagents, alkylation, reduction,
asymmetric synthesis
Tetramic acids [pyrrolidine-2,4-diones (1)] and methyl
tetramates 2 bearing different C-3 acyl groups and C-5
substituents are key frameworks found in a number of
bioactive natural products (Figure 1).1 For example, 5-
methyltetramic acid (1a) is found in melophlins [e.g.
melophlin B (3)];2 methyl 5-methyltetramate (2a) is found
in both dysideapyrrolidone3 and mirabimide E (4),4 a solid
tumor selective cytotoxin isolated from the terrestrial blue
green alga Scytonema mirabile UH strain BY-8-1; methyl
5-isopropyltetramate (2b) is found in dysidin5 and
malyngamide X,6 while dolapyrrolidone (Dpy; 2d) is a
component of antineoplastic dolastatin 15 (5), isolated
from the Indian Ocean sea hare Dolabella auricularia.7
Molecules that contain these structural units exhibit a
wide range of biological activities, which include antivi-
ral, antitumor, antibiotic, and antimicrobial activities. For
example, dolastatin 15 (5) and its analogue have entered
phase I and II clinical trials for patients with various can-
cers.8 On recognizing that tetramic acid9 and
pyrrolidinone10 moieties are largely responsible for the bi-
ological activity of these compounds, a series of tetramic
acid derivatives has been synthesized for screening anti-
bacterial agents,11 b-secretase inhibitors,12 inhibitors of
hepatitis C virus RNA-dependent RNA polymerase,13 and
herbicidal agents.14 In addition, 5-alkyltetramic acids 1
are valuable building blocks for the synthesis of pyrro-
lidines,15 pyrrolidin-2-ones16 such as lactacystin,16a and b-
hydroxy-g-amino acids such as statine [(3S,4S)-4-amino-
3-hydroxy-5-methylheptanoic acid],17 which have been
widely used in the design of inhibitor of other aspartic
proteases such as rennin, a key enzyme in the rennin-
angiotensin system and HIV. Consequently, these com-
pounds have attracted much interest from natural product
chemists, synthetic chemists, as well as medicinal chem-
ists.1
A number of efficient methods have been developed for
the synthesis of chiral 5-alkyltetramic acids.13,18,19 How-
ever, most known methods are based on the use of a-ami-
no acids as the chiral pools,20 which may suffer from
partial racemization.17a,18a,21 Moreover, for the synthesis
of methyl 5-alkyltetramates, the commonly used method
involving conversion of 5-alkyltetramic acids into methyl
5-alkyltetramates22 may suffer from racemization.4,19d In
view of SAR study, more flexible methods would be those
allowing a flexible and direct introduction of substituent
at the C-5 position of a tetramate derivative. Recently,
several carbanionic approaches based on intermediates
such as A have been reported (Scheme 1).23 In this regard,
we have reported two flexible approaches to (S)-5-alkyl-
tetramic acid24a and methyl (R)-5-alkyltetramate24b deriv-
atives. As a continuation of our studies in this area, we
now report a complementary yet flexible carbocationic
synthon B based approach25 to methyl 5-alkyltetramate
derivatives 6 using (S)-phenylglycinol as a chiral auxilia-
ry.26–28
Figure 1
To test the feasibility of the method, the reductive alkyla-
tion of achiral 3-methoxymaleimide 8a was first investi-
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(8a) was synthesized with an overall 55% yield by
condensation29 of maleic anhydride with benzylamine,
followed by bromination and methanolysis30 of the result-
ing maleimide 11a (Scheme 2).
Scheme 2 Synthesis of the (S)-3-methoxymaleimide derivatives.
Reagents and conditions: (a) HMDS, ZnBr2, toluene, 4 h, 80 °C (for
the synthesis of 11a, 11b); (b) (i) THF, 4 h, r.t.; (ii) HMDS, ZnCl2,
toluene, 6 h, 80 °C (for the synthesis of 11c); (c) (i) Br2, CCl4, reflux,
1 h; (ii) Et3N, THF, 0 °C to r.t., 2–4 h; (d) MeOH, Et3N, reflux, 3 h
The reaction of 3-methoxymaleimide 8a with an excess of
methyl magnesium iodide at –78 °C, followed by subjec-
tion of the resulting 5-methyl-5-hydroxytetramate to bo-
ron trifluoride etherate mediated reductive
dehydroxylation with triethylsilane,31 led smoothly to me-
thyl 5-methyltetramate 15a in 88% yield as the only ob-
servable regioisomer, alongside with 6% of a dehydrated
product 16a (Scheme 3). This means that the methyl mag-
nesium iodide addition is highly C-2 regioselective, which
is in agreement with that reported by Pattenden,25a and can
be rationalized by the chelation effect of the C-3 methoxy
group.32 Similar stepwise reductive n-butylation of 8a
gave the desired 14b and 15b in 96% and 90% yields, re-
spectively. Noteworthy is that the use of more reactive n-
butyllithium gave only 50% yield (75% conversion) and
modest C-2 regioselectivity (regioisomeric ratio of C-2/
C-5 = 83:17).
The reductive alkylation of the chiral nonracemic 3-meth-
oxymaleimide derivative 8b {[a]D20 –1.77 (c 1.3,
CHCl3)}, prepared in 50% overall yield from (S)-a-meth-
ylbenzylamine (9b) according to Scheme 2, was next in-
vestigated. As can be seen from Scheme 3, the stepwise
reductive alkylation of 3-methoxymaleimide 8b gave the
desired tetramates 18a–c in good yields, and only one re-
gioisomer was obtained in each case. However, the dia-
stereoselectivities were either low or modest, and the
diastereomers are inseparable by flash chromatography.
The stereochemistry of the newly formed stereocenters
was not determined.
Scheme 3
To improve the diastereoselectivity of the reductive dehy-
droxylation, and in particular, to facilitate the separation
of diastereomers, we next turned our attention to the step-
wise reductive alkylation of (S)-3-methoxymaleimide de-
rivative 8c {[a]D20 –46.2 (c 1.4, CHCl3)}, which was
synthesized in an overall yield of 47% from (S)-phenyl-
glycinol by the procedure shown in Scheme 2.
Treatment of the 3-methoxymaleimide (S)-8c with an ex-
cess of methyl magnesium iodide yielded adduct 20a
(R1 = Me) as a separable diastereomeric mixture in 99%
yield (Scheme 4 and Table 1). Addition of ethyl, n-pentyl,
n-hexyl and n-heptyl Grignard reagents gave lower yields
but similar excellent C-2 regioselectivity, along with
some side products (12–15%) which were difficult to pu-
rify, and were tentatively assigned as 22 and 23. In the
case of isobutyl and benzyl magnesium bromides/chlo-
rides, a mixture of 88:12 and 63:37 C-2/C-5 adducts, re-
spectively, was obtained, which were determined after the
subsequent reductive dehydroxylation.
Because the subsequent Lewis acid mediated reductive
dehydroxylation27,28 would proceed via the intermediacy
of the N-acyliminium ion intermediates such as C,33 the
diastereomeric mixtures could be used without further
separation. Hence, after simple flash chromatographic
separation, the products obtained from the methyl magne-
sium iodide addition were subjected to boron trifluoride
















































11a  R = H (71%)
11b  R = Me (85%)
11c  R = CH2OH (81%)
10
9a  R = H
9b  R = Me
9c  R = CH2OH
12a  R = H
12b  R = Me
12c  R = CH2OH
13a  R = H (96%)
13b  R = Me (91%)
13c  R = CH2OH (98%)
8a  R = H (80%)
8b  R = Me (65%)
8c  R = CH2OH (59%)
a or b c
d
  17 (R1 = Me)
a  R2 = Me, 87% 
b  R2 = n-C5H11, 78% 
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−78 °C, 3 h
              18 (R1 = Me)
a  R2 = Me (75%, dr = 43:57)
b  R2 = n-C5H11 (85%, dr = 23:77)
c  R2 = Ph  (90%, dr = 29:71)
16a R1 = H, 6%





14 (R1 = H)
a  R2 = Me, 90% 
b  R2 = n-Bu, 96%
15 (R1 = H)
a  R2 = Me, 88% 
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etherate mediated reductive dehydroxylation with triethyl-
silane. After 21 hours of reaction, a total of three products
24a/25a (52%), 26a (37%), and 27a (7%) were obtained
(Table 1, entry 1). Prolonging of the reaction time to 36
hours led to a further conversion of 26a, giving 24a, 25a
and 27a in 62%, 14%, and 7% yields, respectively. Exten-
sion of this procedure to other Grignard adducts (20b/
21b–20e/21e and 20g/21g) led to similar results (Table 1).
In the case of 20f/21f, in addition to the desired 24f/25f,
the regioisomer 28f was also observed (Figure 2), while
the reductive dehydroxylation of 20h/21h afforded only
cyclized product 26h and dehydrated product 29h
(Figure 2). The structure of 29h was determined by X-ray
diffraction analysis.34
Figure 2
Isolation of the cyclic products 26 indicates that the reduc-
tive dehydroxylation of the Grignard reagent 20 proceed-
ed, at least partially, through the cyclic products 26, which
might serve as useful intermediates for an alternative
highly diastereoselective reductive ring-opening ap-
proach.27,28 To improve the diastereoselectivity of the re-
duction, a cyclization–reductive ring-opening procedure25
was devised (Scheme 5, Method B). Thus, by treatment
with a catalytic amount of p-TsOH in CH2Cl2 at room
temperature, the diastereomeric mixture of N,O-acetals
20a was converted into bicyclic tetramate derivative 26a
(26: R1 = Me; 75%) alongside with an inseparable mixture
of compounds 30a and 27a (combined yield: 8%; Table 2,
entry 1). The stereochemistry of the major diastereomer
26a was determined by NOESY experiments and further
confirmed by single crystal X-ray diffraction analysis.34
The major diastereomer 26a was subjected to TiCl4-medi-
ated reductive ring-opening reaction with Et3SiH
(CH2Cl2, –78 °C),
27,28 which afforded 24a and 25a as a
separable diastereomeric mixture in 91:9 ratio (Table 2,
entry 1).35 The formation of the major diastereomer 24a
means that the reaction of 26a proceeds with retention of






















































































Table 1 Synthesis of Methyl 5-Alkyltetramate Derivatives 24/25 via Stepwise Reductive Alkylation of the 3-Methoxymaleimide Derivative 
(S)-8c (Method A)
Entry Grignard addition Reductive dehydroxylation of 20
R1MgX Yield (%)
a of 20/21 (dr)b Yield (%)a of 24/25 (dr)b Yield (%)a of 26 (time)c Yield (%)a of 27 or 29
1 MeMgI 99 (20a) (ca. 100:0) 52 (84:16); 76 (82:18) 37 (21 h); 0 (36 h) 7 (27a); 7 (27a)
2 EtMgBr 63 (20b) (>98:2) 88 (79:21) 0 0
3 n-C5H11MgBr 78 (20c) (>98:2) 63 (77:23) 15 (64 h) –
4 n-C6H13MgBr 63 (20d) (>98:2) 78 (74:26) 7 (42 h)
5 n-C7H15MgBr 61 (20e) (>98:2) 74 (72:28) 0 0
6 i-BuMgBr 49 (67) (20f/21f) (88:12)d 64 (78:22) 9 4 (27f)
7 PhMgBr 87 (20g) (>98:2) 68 (73:27) 0 –
8 BnMgCl 69 (20h/21h) (63:37)d 0 50 (22 h) 34 (29h)
a Isolated yield.
b dr: diastereoselectivity; ratio determined by chromatographic separation.
c Time used for the reductive dehydroxylation was about 36 h unless otherwise specified.
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cyclic lactam systems.27,28 Similarly, the bicyclic tetra-
mates 26b–h were formed in excellent diastereo-
selectivities and the subsequent reductive ring opening af-
forded 24b–h and 25b–h, respectively in diastereoselec-
tivities ranging from 88:12 to 99:1 (Table 2, entries 2–
8).35 The NMR spectroscopic data of 24a and 24h, 25a
and 25h are identical with those synthesized from (R)-
phenylglycinol by an alternative method,24b except the
sense of optical rotation, indicating that they are enantio-
mers.
Scheme 5
To understand the higher stability of the diastereomers 26
over 30, the structures of 26a and 30a were optimized at
B3LYP/6-31G* level, and single-point energies refined at
the B3LYP/6-31+G** level show that 26a was more sta-
ble than 30a by 3.97 kcal/mol. The stereochemical out-
come and high diastereoselectivity of the TiCl4-mediated
reductive ring opening of the bicyclic lactams 26 can be
rationalized on the basis of both allylic 1,3-interaction36
and Felkin–Anh model,37 originally proposed by Meyers
and co-workers for a related system.27
In summary, starting from the chiral 3-methoxymaleimide
derivative (S)-8c, we have developed a flexible and direct
approach to methyl 5-alkyltetramate derivatives 24 via a
C-2 regioselective Grignard addition, and a highly diaste-
reoselective stepwise cyclization–reductive ring-opening
procedure. This approach is versatile in scope, allowing
the synthesis of various methyl 5-alkyltetramate deriva-
tives which are inaccessible by the commonly used a-ami-
no acid based methods.
Supporting Information for this article is available online at
http://www.thieme-connect.com/ejournals/toc/synlett.
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